Table 9: Primary Outcome and Inclusion Criteria for the Meta-Analysis by Sinno et al. (8).

Primary Outcome	Inclusion Criteria
At 30 days followup: All cause mortality Reinfarction rate Major bleeding events	RCTs Patients randomized within 12 hours of symptom onset to either GpIIbIIIa inhibitors or combination therapy (thrombolytic + GpIIbIIIa inhibitor) followed by preplanned angiography and angioplasty if indicated